July 13, 2010; 75 (2) Articles
Use of anticholinergics and the risk of cognitive impairment in an African American population
N.L. Campbell, M.A. Boustani, K.A. Lane, S. Gao, H. Hendrie, B.A. Khan, J.R. Murrell, F.W. Unverzagt, A. Hake, V. Smith-Gamble, K. Hall
First published July 12, 2010, DOI: https://doi.org/10.1212/WNL.0b013e3181e7f2ab
N.L. Campbell
M.A. Boustani
K.A. Lane
S. Gao
H. Hendrie
B.A. Khan
J.R. Murrell
F.W. Unverzagt
A. Hake
V. Smith-Gamble
Use of anticholinergics and the risk of cognitive impairment in an African American population
N.L. Campbell, M.A. Boustani, K.A. Lane, S. Gao, H. Hendrie, B.A. Khan, J.R. Murrell, F.W. Unverzagt, A. Hake, V. Smith-Gamble, K. Hall
Neurology Jul 2010, 75 (2) 152-159; DOI: 10.1212/WNL.0b013e3181e7f2ab
Citation Manager Formats
Make Comment
See Comments

Article Information
vol. 75 no. 2 152-159
PubMed:
Print ISSN:
Online ISSN:
History:
- First Published July 12, 2010.
Copyright & Usage:
© 2010
Author Disclosures
- N.L. Campbell, PharmD,
- M.A. Boustani, MD, MPH,
- K.A. Lane, MS,
- S. Gao, PhD,
- H. Hendrie, MB, ChB, DSc (Med),
- B.A. Khan, MD,
- J.R. Murrell, PhD,
- F.W. Unverzagt, PhD,
- A. Hake, MD,
- V. Smith-Gamble and
- K. Hall, PhD
- N.L. Campbell, PharmD,
- M.A. Boustani, MD, MPH,
- K.A. Lane, MS,
- S. Gao, PhD,
- H. Hendrie, MB, ChB, DSc (Med),
- B.A. Khan, MD,
- J.R. Murrell, PhD,
- F.W. Unverzagt, PhD,
- A. Hake, MD,
- V. Smith-Gamble and
- K. Hall, PhD
- From Wishard Health Services (N.L.C.); Indiana University Center for Aging Research (M.A.B., H.H.); Regenstrief Institute, Inc. (M.A.B., H.H.); Department of Medicine (M.A.B., K.A.L., S.G., B.A.K., A.H.), Indiana University School of Medicine; Departments of Psychiatry (H.H., F.W.U., V.S.-G., K.H.), Pathology and Laboratory Medicine (J.R.M.), and Neurology (A.H.), Indiana University Indianapolis; and Richard L. Roudebush Veterans Administration Medical Center (V.S.-G.), Indianapolis, IN.
- Address correspondence and reprint requests to Dr. Noll L. Campbell, Wishard Health Services, 1001 West 10th Street, Indianapolis, IN 46202-2872 noll.campbell{at}wishard.edu
Article usage
Cited By...
Letters: Rapid online correspondence
No comments have been published for this article.
REQUIREMENTS
If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
Advertisement
Use of Whole-Genome Sequencing for Mitochondrial Disease Diagnosis
Dr. Robert Pitceathly and Dr. William Macken
► Watch
Related Articles
- No related articles found.
Topics Discussed
Alert Me
Recommended articles
-
Research
Disparities in Cognitive Impairment With Anticholinergic Drug UseA Population-Based StudyMd Motiur Rahman, George Howard, Jingjing Qian et al.Neurology: Clinical Practice, September 11, 2020 -
Articles
The neuroprotective effects of caffeineA prospective population study (the Three City Study)K. Ritchie, I. Carrière, A. de Mendonça et al.Neurology, August 06, 2007 -
Articles
Vascular risk factors and cognitive impairment in a stroke-free cohortF.W. Unverzagt, L.A. McClure, V.G. Wadley et al.Neurology, November 07, 2011 -
Articles
Spectrum of cognitive impairment in neurocysticercosisDifferences according to disease phaseC.L. Rodrigues, D.C. de Andrade, J.A. Livramento et al.Neurology, March 07, 2012